Growth Metrics

Invivyd (IVVD) Share-based Compensation (2021 - 2025)

Invivyd posted quarterly Share-based Compensation of $2.6 million for Q4 2025, down 16.13% year-on-year from $3.1 million in Q4 2024, and down 16.56% on a QoQ basis from $3.1 million in Q3 2025.

Invivyd (IVVD) has 5 years of Share-based Compensation data on file, last reported at $2.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 16.13% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2025 stood at $11.6 million (down 41.17% YoY), and the FY2025 full-year result was $11.6 million, down 41.16% from the prior year.
  • Share-based Compensation for Q4 2025 stood at $2.6 million, down from $3.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $8.5 million in Q2 2024 and bottomed at $587000.0 in Q1 2021.
  • The 5-year median for Share-based Compensation is $4.3 million (2023), against an average of $4.5 million.
  • The widest annual swing landed in 2022, when Share-based Compensation soared 237.82%; it then sank 62.54% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $7.9 million in 2021, then fell by 24.83% to $5.9 million in 2022, then decreased by 26.44% to $4.3 million in 2023, then fell by 29.63% to $3.1 million in 2024, then fell by 16.13% to $2.6 million in 2025.
  • The last three Share-based Compensation figures came in at $2.6 million (Q4 2025), $3.1 million (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 892,057.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 305,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 166.40 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 257.40 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 70.15 Mn
10 Invivyd 208.38 Mn -18.31 Mn - 2.56 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.56 Mn
Dec 31, 2025 2.56 Mn
Sep 30, 2025 3.07 Mn
Sep 30, 2025 3.07 Mn
Jun 30, 2025 3.18 Mn
Jun 30, 2025 3.18 Mn
Mar 31, 2025 2.83 Mn
Mar 31, 2025 2.83 Mn
Dec 31, 2024 3.06 Mn
Dec 31, 2024 3.06 Mn
Sep 30, 2024 2.87 Mn
Sep 30, 2024 2.87 Mn
Jun 30, 2024 8.49 Mn
Jun 30, 2024 8.49 Mn
Mar 31, 2024 5.38 Mn
Mar 31, 2024 5.38 Mn
Dec 31, 2023 4.34 Mn
Dec 31, 2023 4.34 Mn
Sep 30, 2023 4.26 Mn
Sep 30, 2023 4.26 Mn
Jun 30, 2023 4.68 Mn
Jun 30, 2023 4.68 Mn
Mar 31, 2023 5.40 Mn
Mar 31, 2023 5.40 Mn
Dec 31, 2022 5.91 Mn
Dec 31, 2022 5.91 Mn
Sep 30, 2022 7.40 Mn
Sep 30, 2022 7.40 Mn
Jun 30, 2022 6.36 Mn
Jun 30, 2022 6.36 Mn
Mar 31, 2022 1.98 Mn
Mar 31, 2022 1.98 Mn
Dec 31, 2021 7.86 Mn
Dec 31, 2021 7.86 Mn
Sep 30, 2021 5.98 Mn
Sep 30, 2021 5.98 Mn
Jun 30, 2021 3.34 Mn
Jun 30, 2021 3.34 Mn
Mar 31, 2021 587,000.00
Mar 31, 2021 587,000.00